Tools
Tools
Sewpersadh, N.S. and Dalwai, T. 
ORCID: 0000-0001-5754-5384,
2024.
Managerial ability, intellectual property rights, R&D: does firm age play a role?
Competitiveness Review, 34 (7), pp. 61-87.
ISSN 1059-5422
|
Text
1897121_Dalwai.pdf - Published version Download (264kB) | Preview |
Abstract
Purpose: The interplay between individual and collective creativity and its translation into innovation is a critical yet complex challenge in the ever-evolving innovation landscape. This study delves into the intricate relationship between managerial ability, intellectual property rights (IPRs) and research and development (R&D) investments contextualized within the dynamics of leverage, firm life stages and tangibility for pharmaceutical firms in the Asia-Pacific region. By exploring how micro-level factors influence macro-level innovation processes, this study aims to contribute to the broader understanding of creativity and innovation, a theme at the heart of addressing contemporary global challenges.
Design/methodology/approach: Econometric methodologies were used to analyse a data set comprising 2,660 firm-year observations spanning the decade from 2011 to 2020.
Findings-A key finding was that companies with lower managerial prowess strategically leverage R&D intensity to signal their value to the market and accrue reputational currency. The research unearths a significant positive relationship between managerial ability, IPRs and R&D investment. In environments characterized by strong managerial acumen and robust IPR safeguards, firms exhibit a heightened propensity to allocate resources to R&D endeavours. This underscores the role of intellectual leadership and legal protections in shaping R&D strategies within the pharmaceutical domain. Incorporating firm life stages as a moderating factor reveals that firm maturity fundamentally influences the interplay between managerial ability, IPRs and R&D expenditure.
Originality/value: These findings’ implications resonate profoundly within policy-making circles and pharmaceutical firms’ day-to-day operational strategies, underscoring the pivotal role of intellectual capital and legal safeguards in shaping the future of innovation in the Asia-Pacific pharmaceutical sector.
| Item Type: | Journal article | ||||||
|---|---|---|---|---|---|---|---|
| Publication Title: | Competitiveness Review | ||||||
| Creators: | Sewpersadh, N.S. and Dalwai, T. | ||||||
| Publisher: | Emerald | ||||||
| Date: | May 2024 | ||||||
| Volume: | 34 | ||||||
| Number: | 7 | ||||||
| ISSN: | 1059-5422 | ||||||
| Identifiers: |
|
||||||
| Divisions: | Schools > Nottingham Business School | ||||||
| Record created by: | Jonathan Gallacher | ||||||
| Date Added: | 23 May 2024 16:06 | ||||||
| Last Modified: | 23 May 2024 16:06 | ||||||
| URI: | https://irep.ntu.ac.uk/id/eprint/51468 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
